Elanco Rebates
You're in the right place to redeem a rebate.
Find an offer to redeem by searching with your offer code or browsing the list of available offers to redeem below.
Redeem a New Rebate
If you don’t know your rebate offer code, view the list of available rebates below.
Browse All Rebates
Rebate Offer | Offer Code | Offer Details | Rebate Value | Valid Purchase Dates | Submission Deadline | |
---|---|---|---|---|---|---|
Offer CodeCRD2023 | Offer Details 6 doses | Rebate Value $15 | Valid Purchase Dates1/1/23 - 12/31/23 | Valid Purchase Dates3/1/2024 | Claim Rebate | |
Offer CodeCAT2023 | Offer Details 6 doses | Rebate Value $15 | Valid Purchase Dates1/1/23 - 12/31/23 | Valid Purchase Dates3/1/2024 | Claim Rebate | |
![]() | Offer CodeINT2023 | Offer Details 6 doses | Rebate Value $6 | Valid Purchase Dates1/1/23 - 12/31/23 | Valid Purchase Dates3/1/2024 | Claim Rebate Offer also valid for Interceptor® (milbemycin oxime) purchases. |
Offer CodeINCR23 | Offer Details 6 doses of each product | Rebate Value $25 | Valid Purchase Dates1/1/23 - 12/31/23 | Valid Purchase Dates3/1/2024 | Claim Rebate Offer also valid for Interceptor® (milbemycin oxime) purchases. | |
Offer CodeSER2023 | Offer Details 1 collar | Rebate Value $10 | Valid Purchase Dates1/1/23 - 12/31/23 | Valid Purchase Dates3/1/2024 | Claim Rebate | |
Offer CodeINSER23 | Offer Details 1 collar and 6 doses | Rebate Value $20 | Valid Purchase Dates1/1/23- 12/31/23 | Valid Purchase Dates3/1/2024 | Claim Rebate Offer also valid for Interceptor® (milbemycin oxime) purchases. |
Bexacat™ (bexagliflozin tablets)
Important Safety Information:
Before using this product, it is important to read the entire product insert, including the boxed warning. See package insert for full prescribing information.
Cats treated with Bexacat may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death. Development of these conditions should be treated promptly, including insulin administration and discontinuation of Bexacat. Do not use Bexacat in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of Bexacat in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of Bexacat, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death. Sudden onset of hyporexia/anorexia, lethargy, dehydration, diarrhea that is unresponsive to conventional therapy, or weight loss in cats receiving Bexacat should prompt immediate discontinuation of Bexacat and assessment for diabetic ketoacidosis, regardless of blood glucose level. Bexacat should not be initiated in cats with pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis. Due to risk of severe adverse reactions, do not use Bexacat in cats with evidence of hepatic disease or reduced renal function. Consult a physician in case of accidental ingestion by humans.